Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin

Neuro-Oncology

Volumn 3, Issue 1, 2001, Pages 11-21

  Janss, Anna J ^a   Maity, Amit ^b   Tang, Cheng Bi ^a   Muschel, Ruth J ^b   McKenna, W Gillies ^b   Sutton, Leslie ^a   Phillips, Peter C ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CYCLIN A; CYCLIN B; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DNA TOPOISOMERASE; ENZYME INHIBITOR; MESSENGER RNA; TUMOR PROTEIN;

ARTICLE; BIOSYNTHESIS; BRAIN TUMOR; CELL CULTURE; CELL CYCLE G2 PHASE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; MEDULLOBLASTOMA; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; CAMPTOTHECIN; CDC2 PROTEIN KINASE; CYCLIN A; CYCLIN B; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MEDULLOBLASTOMA; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0035235066     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851700000259     Document Type: Article

References (56)

1. Aida, T., and Bodell, W.J. (1987) Effect of caffeine on cytotoxicity and sister chromatid exchange Induction in sensitive and resistant rat brain tumor cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 47, 5052-5058.
2. 2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat. Res. 140, 393-400.
3. Biegel, J.A., Burk, C.D., Barr, F.G., and Emanuel, B.S. (1992) Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res. 52, 3391-3395.
4. Bigner, S.H., Schold, S.C., Friedman, H.S., Mark, J., and Bigner, D.D. (1989) Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic mice. Cancer Genet Cytogenet. 40, 111-120.
5. Bredel, M., Pollack, I.F., Freund, J.M., Rusnak, J., and Lazo, J.S. (1999) Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion. J. Neurooncol. 41, 9-20.
6. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
7. Cox, L.S., and Lane, D.P. (1995) Tumor suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17, 501-508.
8. Desai, D., Wessling, H.C., Fisher, R.P., and Morgan, D.O. (1995) Effects of phosphorylation by CAK on cydin binding by CDC2 and CDK2. Mol. Cell. Biol. 15, 345-350.
9. Dunphy, W.G. (1994) The descision to enter mitosis. Trends Cell Biol. 4, 202-207.
10. Friedman, H.S., Colvin, O.M., Skapek, S.X., Ludeman, S.M., Elion, G.B., Schold, S.C., Jr., Jacobsen, P.F., Muhlbaier, I.H., and Bigner, D.D. (1988) Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res. 48, 4189-4195.
11. Fults, D., Brockmeyer, D., Tullous, M.W., Pedone, C.A., and Cawthon, R.M. (1992) p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res. 52, 674-679.
12. Gafanovich, A., Ramu, N., Krichevsky, S., Pe'er, J., Amir, G., and Ben-Yehuda, D. (1999) Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms. Cancer 85, 504-510.
13. Gould, K.L., and Nurse, P. (1989) Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 342, 39-45.
14. He, J., Olson, J.J., and James, C.D. (1995) Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55, 4833-4836.
15. He, X.M., Wikstrand, C.J., Friedman, H.S., Bigner, S.H., Pleasure, S., Trojanowski, J.Q., and Bigner, D.D. (1991) Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest 64, 833-843.
16. Heintz, N., Sive, H.L., and Roeder, R.G. (1983) Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in half-lives of individual histone mRNAs during the HeLa cell cycle. Mol. Cell Biol. 3, 539-550.
17. 2/M progression. Mol. Cell 1, 3-11.
18. Horwitz, S.B., Chang, C.-K., and Grollman, A.P. (1971) Studies on camptothecin. I. Effects of nudeic add and protein synthesis. Mol. Pharmacol. 7, 632-644.
19. Howng, S.L., Hwang, S.L., Chai, C.Y., and Lin, H.J. (1996) Immunohistochemical pattern of P53 protein in human astrocytic tumors. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih [Kao Hsiung J. Med Sci.] 12, 279-284.
20. 2 checkpoint through cydin B1. Proc. Natl. Acad. Sci. U.S.A. 96, 2147-2152.
21. James, C.D., He, J., Carlbom, E., Mikkelsen, T., Ridderheim, P.A., Cavenee, W.K., and Collins, V.P. (1990) Loss of genetic information in central nervous system tumors common to children and young adults. Genes Chromosomes Cancer 2, 94-102.
22. Janss, A.J., Cnaan, A., Zhao, H., Shpilsky, A., Levow, C., Sutton, L., and Phillips, P.C. (1998a) Synergystic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines. Anticancer Drugs 9, 641-652.
23. Janss, A.J., Levow, C., Bernhard, E.J., Muschel, R.J., McKenna, W.G., Sutton, L., and Phillips, P.C. (1998b) Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell lines. Exp. Cell Res. 243, 29-38.
24. Johnson, D.G., and Walker, C.L. (1999) Cydins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39, 295-312.
25. 2 delay in HeLa cells. Cancer Res. 57, 753-758.
26. Kessel, D. (1971) Effects of camptothecin on RNA synthesis in leukemia L1210 cells. Biochim. Biophys. Acta 246, 225-232.
27. Liu, F., Stanton, J.J., Wu, Z., and Piwnica-Worms, H. (1997) The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol. 17, 571-583.
28. 2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cydin B1 complexes. Mol. Cell. Biol. 19, 5113-5123.
29. Lock, R.B. (1992) Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphrylation and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res. 52, 1817-1822.
30. Lock, R.B., and Ross, W.E. (1990) Possible role for p34cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res. 50, 3767-3771.
31. Maity, A., McKenna, W.G., and Muschel, R.J. (1995) Evidence for post-transcriptional regulation of cydin B1 mRNA in the cell cycle and following irradiation in HeLa cells. EMBO J 14, 603-609.
32. 2 arrest following DNA damage. Oncogene 13, 1647-1657.
33. Matsuoka, S., Huang, M., and Elledge, S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-1897.
34. 2 delay in radiation resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and V-myc. Radiat. Res. 125, 283-287.
35. 2 block induced by ionizing radiation. Cancer Res. 51, 5113-5117.
36. Nehlig, A., Daval, J.-L., and Debry, G. (1992) Caffeine and the central nervous system: Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev. 17, 139-170.
37. Nurse, P. (1994) Ordering S phase and M phase in the cell cycle. Cell 79, 547-550.
38. O'Connor, P.M., and Kohn, K.W. (1992) A fundamental role for cell cycle regulation in chemosensitivity of cancer cells? Semin. Cancer Biol. 3, 409-416.
39. O'Connor, P.M., Ferns, D.K., White, G.A., Pines, J., Hunter, T., Longo, D.L., and Kohn, K.W. (1992) Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ. 3, 43-52.
40. 2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J. Biol. Chem. 268, 8298-8308.
41. Ohi, R., and Goud, K.L. (1999) Regulating the onset of mitosis. Curr. Opin. Cell Biol. 11, 267-273.
42. Packer, R.J., Sutton, L.N., Elterman, R., Lange, B., Goldwein, J., Nicholson, H.S., Mulne, L., Boyett, J., D'Angio, G., Wechsler-Jentzsch, K., Reaman, G., Cohen, G.H., Bruce, D.A., Torke, L.B., Molloy, P., Ryan, J., LaFond, D., Evans, A.E., and Schut, L. (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J. Neurosurg. 81, 690-698.
43. Pagano, M., Peperkok, R., Verde, F., Ansorge, W., and Draetta, G. (1992) Cyclin A is required at two points in the human cell cycle. EMBO J. 11, 961-971.
44. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
45. Prasad, M.V., Dermott, J.M., Heasley, L.E., Johnson, G.L., and Dhanasekaran, N. (1995) Activation of Jun kinase/stress-activated protein kinase by GTPase-defident mutants of G alpha 12 and G alpha 13. J. Biol. Chem. 270, 18655-18659.
46. Ryan, A.J., Squires, S., Strutt, H.L., and Johnson, R.T. (1991) Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res. 19, 3295-3300.
47. Shao, R.G., Cao, C.X., Shimizu, T., O'Connor, P.M., Kohn, K.W., and Pommier, Y. (1997) Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. Cancer Res. 57, 4029-4035.
48. Shimizu, T., O'Connor, P.M., Kohn, K.W., and Pommier, Y. (1995) Unscheduled activation of cydin B1/cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 5, 228-231.
49. Slichenmyer, W.J., Rowinsky, E.K., Donehower, R.C., and Kaufmann, S.H. (1993) The current status of camptothedn analogues as antitumor agents. J. Natl. Cancer Inst. 85, 271-291.
50. Stewart, D.J., Dahrouge, S., Agboola, O., and Girard, A. (1997) Cranial radiation and concomitant dsplatin and mitomydn-C plus resistance modulators for malignant gliomas. J. Neurooncol. 32, 161-168.
51. 2 checkpoint. EMBO J. 17, 2728-2735.
52. 2 arrest Altered regulation of p34cdc2/cyclin B1. Cancer Res. 52, 1823-1829.
53. Vindelov, L.L., and Christensen, I.J. (1990) A review of techniques and results obtained in one laboratory by integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 11, 753-770.
54. Walker, M.D., and Strike, T.A. (1976) An evaluation of methyl CCNU, BCNU and radiotherapy in the treatment of malignant glioma. Proc. Am. Assoc. Cancer Res. 17, 163-167.
55. 2 checkpoint function in cancer cells with disrupted p53. J. Natl. Cancer Inst. 88, 956-965.
56. Wu, J.K., Ye, Z., and Darras, B.T. (1993) Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. Neurosurgery 33, 824-830.